Neurodegeneration Conference to Feature Alzheimer's and Parkinson's Disease Research Findings by Industry & Academia July 23-24 in Princeton, NJ

Apr 30, 2001, 01:00 ET from Strategic Research Institute

    PRINCETON, N.J., April 30 /PRNewswire/ -- The world industrial and
 academic neuroscience communities will convene in Princeton, NJ on July 23-24,
 2001, to speak, attend, and present posters at the "4th International
 Neurodegeneration in Alzheimer's Disease, Parkinson's Disease and Related
 Disorders" conference, announces Strategic Research Institute.
     Featured among the excellent papers to be presented are "Alzheimer's B-
 Secretase Protein BACE 1:  A target for Treatment of Alzheimer's Disease" to
 be presented by Dr Martin Citron of Amgen, Inc., "The evolution of Neural and
 Stem Cell Therapies for Parkinson's Disease," to be presented by Dr. Ole
 Isacson of Harvard Medical School and McKlean Hospital, "Development of
 Radioligands for in vivo Imaging of Brain Amyloid," to be presented by Dr.
 Virginia M.-Y. Lee of the University of Pennsylvania School Of Medicine, and
 Galantamine:  Results from the Clinical Development Program, to be presented
 by Sean Lilienfeld of Janssen Research Foundation.
     The broad-based meeting is divided into six sections, namely, Parkinson's
 Disease, Novel Therapeutic Targets in Neurodegeneration, Pathophysiology of
 Alzheimer's Disease, Amyloid Processing, Novel Therapeutic Targets for
 Neurodegeneration, and Therapeutic Advances.
     Other presenting companies and academic institutions are Aventis
 Pharmaceuticals, NeoTherapeutics, Pfizer, New York Medical Center, The R.W.
 Johnson Pharmaceutical Research Institute, Binzou People's Hospital -- China,
 Brigham and Women's Hospital, MitoKor, Neurochem, Johns Hopkins University,
 Eli Lilly & Company, Exelexis, Guilford Pharmaceuticals, and ACADIA
 Pharmaceuticals.
 
     To request the agenda, please contact Bebe Anderson at
 banderson@srinstitute.com or 212-967-0095 ext. 255, or Sumeet Hora at
 shora@srinstitute.com or 212-967-0095, ext. 261.  Please include your
 affilation, mailing address, and fax number.
 
     To obtain exhibition details or to inquire about sponsoring a luncheon,
 the reception, or totebag giveaway, contact Mark Alexay at
 malexay@srinstitute.com
 
                     MAKE YOUR OPINION COUNT -- Click Here
                http://tbutton.prnewswire.com/prn/11690X35362480
 
 

SOURCE Strategic Research Institute
    PRINCETON, N.J., April 30 /PRNewswire/ -- The world industrial and
 academic neuroscience communities will convene in Princeton, NJ on July 23-24,
 2001, to speak, attend, and present posters at the "4th International
 Neurodegeneration in Alzheimer's Disease, Parkinson's Disease and Related
 Disorders" conference, announces Strategic Research Institute.
     Featured among the excellent papers to be presented are "Alzheimer's B-
 Secretase Protein BACE 1:  A target for Treatment of Alzheimer's Disease" to
 be presented by Dr Martin Citron of Amgen, Inc., "The evolution of Neural and
 Stem Cell Therapies for Parkinson's Disease," to be presented by Dr. Ole
 Isacson of Harvard Medical School and McKlean Hospital, "Development of
 Radioligands for in vivo Imaging of Brain Amyloid," to be presented by Dr.
 Virginia M.-Y. Lee of the University of Pennsylvania School Of Medicine, and
 Galantamine:  Results from the Clinical Development Program, to be presented
 by Sean Lilienfeld of Janssen Research Foundation.
     The broad-based meeting is divided into six sections, namely, Parkinson's
 Disease, Novel Therapeutic Targets in Neurodegeneration, Pathophysiology of
 Alzheimer's Disease, Amyloid Processing, Novel Therapeutic Targets for
 Neurodegeneration, and Therapeutic Advances.
     Other presenting companies and academic institutions are Aventis
 Pharmaceuticals, NeoTherapeutics, Pfizer, New York Medical Center, The R.W.
 Johnson Pharmaceutical Research Institute, Binzou People's Hospital -- China,
 Brigham and Women's Hospital, MitoKor, Neurochem, Johns Hopkins University,
 Eli Lilly & Company, Exelexis, Guilford Pharmaceuticals, and ACADIA
 Pharmaceuticals.
 
     To request the agenda, please contact Bebe Anderson at
 banderson@srinstitute.com or 212-967-0095 ext. 255, or Sumeet Hora at
 shora@srinstitute.com or 212-967-0095, ext. 261.  Please include your
 affilation, mailing address, and fax number.
 
     To obtain exhibition details or to inquire about sponsoring a luncheon,
 the reception, or totebag giveaway, contact Mark Alexay at
 malexay@srinstitute.com
 
                     MAKE YOUR OPINION COUNT -- Click Here
                http://tbutton.prnewswire.com/prn/11690X35362480
 
 SOURCE  Strategic Research Institute